Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Dec;15(2):2267185.
doi: 10.1080/19490976.2023.2267185. Epub 2023 Oct 10.

Microbial-host-isozyme: unveiling a new era in microbiome-host interaction

Affiliations
Comment

Microbial-host-isozyme: unveiling a new era in microbiome-host interaction

Lei Miao et al. Gut Microbes. 2023 Dec.

Abstract

Wang K. et al. introduced the concept of Microbial-Host isozymes (MHIs) and highlighted their role in mediating microbiota-host interactions. They identified bacterial-derived DPP4 as an isoenzyme affecting glucose tolerance and showed that host DPP4 inhibitors may not effectively target bacterial DPP4. They developed an MHI screen system, identifying 71 MHIs in healthy gut microbiota. Among them, DPP4 isozymes degrade GLP-1, explaining variable responses to sitagliptin. This breakthrough opens new avenues for metabolic disorder treatment. However, the complex nature of gut symbiotic bacteria requires further research to understand MHI mechanisms, regulatory roles, and interactions with the host. Precise interventions in gut microbiota offer personalized approaches to metabolic diseases.

Keywords: Microbial-Host isozymes; metabolic diseases.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
Microbial-host-isozyme mining and verification system.

Comment on

References

    1. Wang K, Zhang Z, Hang J, Liu J, Guo F, Ding Y, Li M, Nie Q, Lin J, Zhuo Y, et al. Microbial-host-isozyme analyses reveal microbial DPP4 as a potential antidiabetic target. Science (New York, NY). 2023;381(6657):eadd5787. doi:10.1126/science.add5787. - DOI - PubMed
    1. Fan Y, Pedersen O.. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. 2021;19(1):55–2. doi:10.1038/s41579-020-0433-9. published Online First: 2020/09/06. - DOI - PubMed
    1. Lynch SV, Pedersen O, Phimister EG. The human intestinal microbiome in health and disease. N Engl J Med. 2016;375(24):2369–2379. published Online First: 2016/12/16. doi:10.1056/NEJMra1600266. - DOI - PubMed
    1. Liu Y, Jarman J, Low Y, Augustijn HE, Huang S, Chen H, DeFeo ME, Sekiba K, Hou B-H, Meng X, et al. A widely distributed gene cluster compensates for uricase loss in hominids. Cell. 2023;186(16):3400–13.e20. doi:10.1016/j.cell.2023.06.010. - DOI - PMC - PubMed
    1. Maini Rekdal V, Bess E, Bisanz J, Turnbaugh PJ, Balskus EP. Discovery and inhibition of an interspecies gut bacterial pathway for levodopa metabolism. Science (New York, NY). 2019;364(6445). doi:10.1126/science.aau6323. - DOI - PMC - PubMed

LinkOut - more resources